Free Trial

Edsel B Ford II retires from Ford board, more Fords join

Edsel B. Ford II
In this Wednesday, May 30, 2007, file photo, Edsel B. Ford II speaks at the Mackinac policy conference on Michigan's Mackinac Island, Mich. Ford II is retiring from the board of Ford Motor after serving as a board member for 33 years. The automaker also named some other members of the famous family as board nominees. Board nominees will be up for election at Ford's annual meeting on May 13, 2021. (Charles V. Tines/Detroit News via AP)

DETROIT (AP) — Edsel B. Ford II is retiring from the board of Ford Motor and will be replaced by another member of the Ford family.

Two members of the Ford family will actually join the board because like Edsel Ford, John Lechleiter, the retired chairman and CEO of Eli Lilly, also served notice that he does not want to be considered for re-election.

Edsel Ford has been on the board for 33 years.

The Detroit carmaker is nominating Alexandra Ford English and Henry Ford III, both great-great grandchildren of company founder Henry Ford, as replacements.

Ford English is currently a director in corporate strategy at the company. Henry Ford III is the son of Edsel B. Ford II. He's currently a director in Ford's investor relations department.

Board nominees will be up for election at Ford's annual meeting on May 13.

Should You Invest $1,000 in Eli Lilly and Company Right Now?

Before you consider Eli Lilly and Company, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list.

While Eli Lilly and Company currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Eli Lilly and Company (LLY)
4.967 of 5 stars
$811.61-1.4%0.64%87.74Moderate Buy$997.22
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

Pelosi Bets Big on AI: Her Top 5 Stock Picks

Pelosi Bets Big on AI: Her Top 5 Stock Picks

MarketBeat's Thomas Hughes breaks down Pelosi's stock picks, her strategy, and what these moves mean for the future of the AI industry.

Recent Videos

5 Stocks to BUY NOW in February 2025
How To Invest in Crypto as A Complete BEGINNER in 2025
3 AI Bargain Stocks to BUY NOW After the DeepSeek Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines